Shopping Cart
- Remove All
- Your shopping cart is currently empty
Dusigitumab (MEDI 573) is a human IgG2λ monoclonal antibody targeting insulin-like growth factors IGF2 and IGF1, offering therapeutic potential for conditions related to these proteins [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $247 | 2-4 weeks | |
5 mg | $647 | 2-4 weeks | |
10 mg | $987 | 2-4 weeks |
Description | Dusigitumab (MEDI 573) is a human IgG2λ monoclonal antibody targeting insulin-like growth factors IGF2 and IGF1, offering therapeutic potential for conditions related to these proteins [1]. |
Alias | MEDI 573 |
Cas No. | 1204390-13-5 |
Storage | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.